NCT04262609Active, not recruiting
Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy
Faecal Incontinence in Prostate Cancer Survivors Treated With Moderately Hypofractionated Radiotherapy
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
The objective of the study is to determine the incidence of faecal incontinence in prostate cancer survivors treated with moderately hypofractionated radiation therapy and correlate the dose received by the anal sphincter with the degree of faecal incontinence.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 5 Feb 2020
- Start date
- 1 Jul 2019
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Consorci Sanitari de Terrassa
- Diseases
- Prostate cancer
- NCT number
- NCT04262609
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Jul 2019 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Relapse of prostate cancer
- Other active cancer
- Mental disorder
Who the study is looking for
- Prostate cancer survivors treated in our department by hypofractionated radiotherapy
Age in the registry: 18 years to - · Sex: Male
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consorci Sanitari de Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.